Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Genetic pathogenesis, diagnosis, and treatment of short-chain 3-hydroxyacyl-coenzyme A dehydrogenase hyperinsulinism

Fig. 3

Mechanisms of insulin dysregulation in SCHAD deficiency. In SCHAD-deficient islets, loss of the inhibitory protein–protein interaction of SCHAD on GDH results in increased sensitivity of GDH to allosteric activation of leucine. Glutamine plus leucine has the strongest stimulatory effect on islets in vitro assays. On top of glutamine plus leucine stimulation, increasing alanine secondary to more insulin release, as the TCA cycle can produce more ATP. GDH glutamate dehydrogenase, SCHAD short-chain 3-hydroxyacyl-CoA dehydrogenase, α-KG α-ketoglutarate, OAA oxaloacetate, and TCA tricarboxylic acid

Back to article page